Joshua M Thiede (Joshua Thiede)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Cerebrospinal Fluid

Pulmonary Tuberculosis

Top Venues

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua M Thiede, Jenna Kelly Dick, Nicholas N Jarjour, Venkatramana D Krishna, Lily Qian, Jules A Sangala, Kellie Benzow, Kul Karanjeet, Shine Chin, Orion Rainwater, Maxim C-J Cheeran, Kristin A Hogquist, Stephen C Jameson, Geoffrey Thomas Hart, Tyler D Bold, Michael D Koob
Human ACE2 Gene Replacement Mice Support SARS-CoV-2 Viral Replication and Nonlethal Disease Progression. ImmunoHorizons 8 (9) (2024)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
Abigail R Gress, Christine E Ronayne, Joshua M Thiede, David K Meyerholz, Samuel Okurut, Julia Stumpf, Tailor V Mathes, Kenneth Ssebambulidde, David B Meya, Fiona V Cresswell, David R Boulware, Tyler D Bold
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy. Nature communications 14 (1) (2023)
William E Matchett, Vineet Joag, J Michael Stolley, Frances K Shepherd, Clare F Quarnstrom, Clayton K Mickelson, Sathi Wijeyesinghe, Andrew G Soerens, Samuel Becker, Joshua M Thiede, Eyob Weyu, Stephen O'Flanagan, Jennifer A Walter, Michelle N Vu, Vineet D Menachery, Tyler D Bold, Vaiva Vezys, Marc K Jenkins, Ryan A Langlois, David Masopust
Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity. bioRxiv : the preprint server for biology (2021)
Vineet Joag, Sathi Wijeyesinghe, J Michael Stolley, Clare F Quarnstrom, Thamotharampillai Dileepan, Andrew G Soerens, Jules A Sangala, Stephen D O'Flanagan, Noah V Gavil, Sung-Wook Hong, Siddheshvar Bhela, Sailaja Gangadhara, Eyob Weyu, William E Matchett, Joshua M Thiede, Venkatramana D Krishna, Maxim C-J Cheeran, Tyler D Bold, Rama Rao Amara, Peter Southern, Geoffrey T Hart, Luca Schifanella, Vaiva Vezys, Marc K Jenkins, Ryan A Langlois, David Masopust
Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses. Journal of immunology (Baltimore, Md. : 1950) 206 (5) (2021)
Obinna C Ubah, Eric W Lake, Gihan S Gunaratne, Joseph P Gallant, Marie Fernie, Austin J Robertson, Jonathan S Marchant, Tyler D Bold, Ryan A Langlois, William E Matchett, Joshua M Thiede, Ke Shi, Lulu Yin, Nicholas H Moeller, Surajit Banerjee, Laura Ferguson, Marina Kovaleva, Andrew J Porter, Hideki Aihara, Aaron M LeBeau, Caroline J Barelle
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography. Nature communications 12 (1) (2021)
Jessica K Fiege, Joshua M Thiede, Hezkiel Arya Nanda, William E Matchett, Patrick J Moore, Noe Rico Montanari, Beth K Thielen, Jerry Daniel, Emma Stanley, Ryan C Hunter, Vineet D Menachery, Steven S Shen, Tyler D Bold, Ryan A Langlois
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. PLoS pathogens 17 (1) (2021)
William E Matchett, Vineet Joag, J Michael Stolley, Frances K Shepherd, Clare F Quarnstrom, Clayton K Mickelson, Sathi Wijeyesinghe, Andrew G Soerens, Samuel Becker, Joshua M Thiede, Eyob Weyu, Stephen D O'Flanagan, Jennifer A Walter, Michelle N Vu, Vineet D Menachery, Tyler D Bold, Vaiva Vezys, Marc K Jenkins, Ryan A Langlois, David Masopust
Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity. Journal of immunology (Baltimore, Md. : 1950) 207 (2) (2021)